Home
Scholarly Works
Equity issues rarely addressed in the development...
Journal article

Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study

Abstract

BACKGROUND AND OBJECTIVE: To identify COVID-19 actionable statements (e.g., recommendations) focused on specific disadvantaged populations in the living map of COVID-19 recommendations (eCOVIDRecMap) and describe how health equity was assessed in the development of the formal recommendations. METHODS: We employed the place of residence, race or ethnicity or culture, occupation, gender or sex, religion, education, socio-economic status, and social capital-Plus framework to identify statements focused on specific disadvantaged populations. We assessed health equity considerations in the evidence to decision frameworks (EtD) of formal recommendations for certainty of evidence and impact on health equity criteria according to the Grading of Recommendations, Assessment, Development, and Evaluations criteria. RESULTS: We identified 16% (124/758) formal recommendations and 24% (186/819) good practice statements (GPS) that were focused on specific disadvantaged populations. Formal recommendations (40%, 50/124) and GPS (25%, 47/186) most frequently focused on children. Seventy-six percent (94/124) of the recommendations were accompanied with EtDs. Over half (55%, 52/94) of those considered indirectness of the evidence for disadvantaged populations. Considerations in impact on health equity criterion most frequently involved implementation of the recommendation for disadvantaged populations (17%, 16/94). CONCLUSION: Equity issues were rarely explicitly considered in the development COVID-19 formal recommendations focused on specific disadvantaged populations. Guidance is needed to support the consideration of health equity in guideline development during health emergencies.

Authors

Dewidar O; Bondok M; Abdelrazeq L; Aliyeva K; Solo K; Welch V; Brignardello-Petersen R; Mathew JL; Hazlewood G; Pottie K

Journal

Journal of Clinical Epidemiology, Vol. 161, , pp. 116–126

Publisher

Elsevier

Publication Date

September 1, 2023

DOI

10.1016/j.jclinepi.2023.08.002

ISSN

0895-4356

Contact the Experts team